tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market
CNSP
CNS Pharmaceuticals
RESEARCH TOOLSreports
Want to see CNSP full AI Analyst Report?

CNS Pharmaceuticals (CNSP) Income Statement

1,096 Followers

CNS Pharmaceuticals Income Statement

Last quarter (Q4 2025), CNS Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, CNS Pharmaceuticals's net income was $-5.96M. See CNS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.31K$ -4.13K$ -11.76K$ -13.07K
Operating Expenses
$ 15.99M$ 14.90M$ 18.86M$ 14.92M$ 14.47M
Depreciation and Amortization
$ 3.92K$ 3.31K$ 4.13K$ 11.76K$ 13.07K
EBITDA
$ -15.83M$ -14.84M$ -18.86M$ -15.26M$ -14.47M
Operating Income
$ -15.99M$ -14.90M$ -18.87M$ -14.93M$ -14.49M
Other Income/Expenses
$ 136.00K$ 44.14K$ 13.88K$ -341.17K$ -9.29K
Pretax Income
$ -15.85M$ -14.86M$ -18.85M$ -15.27M$ -14.50M
Net Income
$ -15.85M$ -14.86M$ -18.85M$ -15.27M$ -14.50M
Per Share Metrics
Basic EPS
$ -35.75$ -466.44$ -150.11K$ -336.50K$ -495.03K
Diluted EPS
$ -35.75$ -466.44$ -150.11K$ -336.50K$ -495.03K
Weighted Average Shares Outstanding
 443.37K 31.85K---
Weighted Average Shares Outstanding (Diluted)
 443.37K 31.85K---
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History